Manfred Schwab

17.2k total citations · 6 hit papers
150 papers, 12.4k citations indexed

About

Manfred Schwab is a scholar working on Neurology, Molecular Biology and Genetics. According to data from OpenAlex, Manfred Schwab has authored 150 papers receiving a total of 12.4k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Neurology, 79 papers in Molecular Biology and 39 papers in Genetics. Recurrent topics in Manfred Schwab's work include Neuroblastoma Research and Treatments (78 papers), Cancer, Hypoxia, and Metabolism (20 papers) and Genomic variations and chromosomal abnormalities (16 papers). Manfred Schwab is often cited by papers focused on Neuroblastoma Research and Treatments (78 papers), Cancer, Hypoxia, and Metabolism (20 papers) and Genomic variations and chromosomal abnormalities (16 papers). Manfred Schwab collaborates with scholars based in Germany, United Kingdom and United States. Manfred Schwab's co-authors include J. Michael Bishop, Harold Varmus, Garrett M. Brodeur, Frank Westermann, Kari Alitalo, Robert C. Seeger, Frank Berthold, Javed Khan, Jun S. Wei and Lukas C. Amler and has published in prestigious journals such as Nature, Science and Journal of Biological Chemistry.

In The Last Decade

Manfred Schwab

143 papers receiving 12.0k citations

Hit Papers

Classification and diagno... 1983 2026 1997 2011 2001 1984 1983 1983 1984 500 1000 1.5k

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Manfred Schwab 8.1k 5.4k 2.9k 2.5k 2.2k 150 12.4k
Frank Berthold 7.9k 1.0× 9.9k 1.8× 4.3k 1.5× 2.9k 1.1× 1.2k 0.5× 320 16.4k
Javed Khan 6.2k 0.8× 1.7k 0.3× 2.0k 0.7× 2.2k 0.9× 905 0.4× 350 10.9k
Frank Westermann 6.3k 0.8× 2.4k 0.4× 3.2k 1.1× 1.4k 0.5× 663 0.3× 118 8.9k
Daniel J. Brat 7.8k 1.0× 3.4k 0.6× 4.9k 1.7× 3.6k 1.5× 814 0.4× 312 23.3k
Rogier Versteeg 7.4k 0.9× 3.4k 0.6× 2.5k 0.9× 2.4k 1.0× 1.5k 0.7× 174 10.8k
Christian Hartmann 5.4k 0.7× 2.3k 0.4× 3.9k 1.4× 1.2k 0.5× 440 0.2× 306 14.7k
Jane Fridlyand 6.7k 0.8× 555 0.1× 2.0k 0.7× 3.5k 1.4× 1.4k 0.6× 68 10.6k
Kenneth Aldape 13.1k 1.6× 2.4k 0.4× 8.1k 2.8× 6.6k 2.7× 1.3k 0.6× 369 27.8k
Rameen Beroukhim 10.0k 1.2× 1.2k 0.2× 6.1k 2.1× 4.1k 1.7× 2.2k 1.0× 155 17.0k
Thomas M. Gress 6.4k 0.8× 2.3k 0.4× 2.9k 1.0× 8.5k 3.4× 764 0.3× 285 15.8k

Countries citing papers authored by Manfred Schwab

Since Specialization
Citations

This map shows the geographic impact of Manfred Schwab's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manfred Schwab with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manfred Schwab more than expected).

Fields of papers citing papers by Manfred Schwab

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manfred Schwab. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manfred Schwab. The network helps show where Manfred Schwab may publish in the future.

Co-authorship network of co-authors of Manfred Schwab

This figure shows the co-authorship network connecting the top 25 collaborators of Manfred Schwab. A scholar is included among the top collaborators of Manfred Schwab based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manfred Schwab. Manfred Schwab is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sagulenko, Evgeny, et al.. (2012). Genomic rearrangements at the FRA2H common fragile site frequently involve non-homologous recombination events across LTR and L1(LINE) repeats. Human Genetics. 131(8). 1345–1359. 13 indexed citations
2.
Henrich, Kai‐Oliver, Tobias Bauer, Johannes H. Schulte, et al.. (2011). CAMTA1 , a 1p36 Tumor Suppressor Candidate, Inhibits Growth and Activates Differentiation Programs in Neuroblastoma Cells. Cancer Research. 71(8). 3142–3151. 64 indexed citations
3.
Schwab, Manfred. (2011). Nevoid Basal Cell Carcinoma Syndrome. PubMed. 19(1). 2513–2513. 14 indexed citations
4.
Muth, Daniel, Isabella Eckerle, Claudia Beisel, et al.. (2010). Transcriptional Repression of SKP2 Is Impaired in MYCN -Amplified Neuroblastoma. Cancer Research. 70(9). 3791–3802. 43 indexed citations
5.
Muth, Daniel, et al.. (2008). Cathepsin D protects human neuroblastoma cells from doxorubicin-induced cell death. Carcinogenesis. 29(10). 1869–1877. 52 indexed citations
6.
Sagi‐Assif, Orit, Shelly Maman, N. Kariv, et al.. (2008). Generation and Characterization of Novel Local and Metastatic Human Neuroblastoma Variants. Neoplasia. 10(8). 817–IN15. 22 indexed citations
7.
Westermann, Frank, Kai-Oliver Henrich, Jun S. Wei, et al.. (2007). High Skp2 Expression Characterizes High-Risk Neuroblastomas Independent of MYCN Status. Clinical Cancer Research. 13(16). 4695–4703. 39 indexed citations
8.
Sagulenko, Evgeny, et al.. (2007). Novel aphidicolin‐inducible common fragile site FRA9G maps to 9p22.2, within the C9orf39 gene. Genes Chromosomes and Cancer. 46(11). 991–999. 16 indexed citations
9.
Deubzer, Hedwig E., Volker Ehemann, Frank Westermann, et al.. (2007). Histone deacetylase inhibitor Helminthosporium carbonum (HC)‐toxin suppresses the malignant phenotype of neuroblastoma cells. International Journal of Cancer. 122(8). 1891–1900. 38 indexed citations
10.
Henrich, Kai-Oliver, Andreas Claas, Christian Praml, et al.. (2007). Allelic variants of CAMTA1 and FLJ10737 within a commonly deleted region at 1p36 in neuroblastoma. European Journal of Cancer. 43(3). 607–616. 10 indexed citations
11.
Wiedemeyer, Ruprecht, et al.. (2003). Ataxin-2 promotes apoptosis of human neuroblastoma cells. Oncogene. 22(3). 401–411. 48 indexed citations
12.
Fulda, Simone, W. Lutz, Manfred Schwab, & Klaus‐Michael Debatin. (1999). MycN sensitizes neuroblastoma cells for drug-induced apoptosis. Oncogene. 18(7). 1479–1486. 112 indexed citations
13.
Schwab, Manfred. (1998). Amplification of oncogenes in human cancer cells. BioEssays. 20(6). 473–479. 149 indexed citations
14.
Praml, Christian, Larissa Savelyeva, Denis Le Paslier, et al.. (1995). Human homologue of a candidate for the Mom1 locus, the secretory type II phospholipase A2 (PLA2S-II), maps to 1p35-36.1/D1S199.. PubMed. 55(23). 5504–6. 24 indexed citations
15.
Gehring, Manuela, et al.. (1993). Combined analysis of prognostic parameters in neuroblastoma. 5. 213–218. 1 indexed citations
16.
Brüderlein, Silke, et al.. (1992). Deletions in the short arm of chromosome 8 are present in up to 90% of human colorectal cancer cell lines. Genes Chromosomes and Cancer. 5(1). 91–95. 34 indexed citations
17.
Schwab, Manfred & Lukas C. Amler. (1990). Amplification of cellular oncogenes: A predictor of clinical outcome in human cancer. Genes Chromosomes and Cancer. 1(3). 181–193. 169 indexed citations
18.
Schwab, Manfred. (1990). Amplification of the MYCN oncogene and deletion of putative tumour suppressor gene in human neuroblastomas. Brain Pathology. 1(1). 41–46. 30 indexed citations
19.
Martinsson, Tommy, Andreas Weith, Celina Cziepluch, & Manfred Schwab. (1989). Chromosome I deletions in human neuroblastomas: Generation and fine mapping of microclones from the distal Ip region. Genes Chromosomes and Cancer. 1(1). 67–78. 55 indexed citations
20.
Schwab, Manfred, et al.. (1979). Genetic basis of susceptibility for neuroblastoma following treatment with N-methyl-N-nitrosourea and X-rays in Xiphophorus.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 39(2 Pt 1). 519–26. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026